Manzara Therapeutics, Inc. — Form D
Manzara Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-20. The offering totals $1.5M, of which $750K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-11-20
- Form: D
- Accession: 0001759533-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $750K
- Remaining: $750K
- Investors: 9
- Date of first sale: 2018-11-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-326174
Issuer
- Name: Manzara Therapeutics, Inc.
- CIK: 0001759533
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 511 AVENUE OF THE AMERICAS, UNIT #952, NEW YORK, NY, 10011
- Phone: 201-962-6337
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Amalavoyal Chari | Director | New York, NY |
| Herschel Rabitz | Director | New York, NY |
| Amalavoyal Chari | Executive Officer | New York, NY |
More